Maravai Lifesciences Holdings Inc (MRVI)
EBITDA Margin
-26.62%
TTM · Period ending:
MRVI EBITDA Margin
Latest reported-26.62%period ending
Latest reported-26.62%period ending
MRVI TTM EBITDA Margin (52.61% → -26.62%)
TTM ebitda margin
High-resolution chart · PNG
MRVI ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -26.6177% | |
| -50.7542% | |
| -79.2014% | |
| -65.582% | |
| -116.5659% | |
| -78.6121% | |
| -60.5425% | |
| 198.0218% | |
| 251.4504% | |
| 254.0688% | |
| 246.5552% | |
| 34.308% | |
| 49.0088% | |
| 62.6201% | |
| 69.0813% | |
| 71.2011% | |
| 74.4884% | |
| 73.5473% | |
| 72.9567% | |
| 68.8893% | |
| 62.7836% | |
| 52.4446% | |
| 48.6709% | |
| 52.6127% |